Rotator Cuff Tear Arthropathy Platelet-Rich Fibrin
Conditions
Interventions
Participants allocated to the intervention group will undergo ultrasound-guided intra-articular glenohumeral injection with autologous injectable platelet-rich fibrin. Injectable platelet-rich fibrin
Sponsors
Hospital Universitário Pedro Ernesto
Hospital Universitário Pedro Ernesto
Eligibility
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients aged 50 years or older; symptomatic glenohumeral osteoarthritis refractory to adequate conservative treatment; candidates for shoulder arthroplasty and awaiting surgery, or patients without adequate clinical conditions for surgery because of high surgical risk
Exclusion criteria
Exclusion criteria: Refusal or inability to sign the informed consent form; psychiatric or cognitive disorder impairing evaluation or follow-up; coagulopathy or international normalized ratio greater than 1.5; malignant neoplasm within the previous 5 years; use of orthobiologic treatment in the same joint within the previous 6 months; stroke or acute myocardial infarction within the previous 3 months; local anesthetic intolerance or allergy; participation in another study within the previous 30 days
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in pain intensity and progressive improvement in shoulder function | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in quality of life, reduction in analgesic consumption (especially opioids), and delay in the need for surgery | — |
Countries
BR
Contacts
Public ContactAndré Luiz de Pessoa
Hospital Universitário Pedro Ernesto da Universidade do Estado do Rio de Janeiro
Outcome results
None listed